GLUE:NASDAQ, Monte Rosa Therapeutics, Inc.

GLUE stock overview

Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ) closed at $8.64 on November 20, 2026, down 3.03% on the day. The stock trades 66.5% below its 52-week high of $25.77 and 1.9% above its 52-week low of $8.48. Over the past year, it lost 45.2%. Monte Rosa Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$8.64
Day change
-3.03%
Volume
2,520,419
Average volume
1,340,935
Market cap
738M+
52-week range
$8.48 – $25.77
50-day average
$10.89
200-day average
$16.51

Price action over the past year

In 252 trading sessions since November 20, 2025, GLUE closed higher on 105 days (42%). Its best day was January 7, 2026 (+45.41%) and its worst was July 31, 2026 (-27.16%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

GLUE news

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.

Similar stocks

Find more stocks like GLUE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.